257 related articles for article (PubMed ID: 28322465)
1. Opioid substitution therapy or hidden opioids are a minefield for nalmefene: an atypical case series of 11 patients in Lorraine.
Yéléhé-Okouma M; Martini H; Lemarié J; Labroca P; Petitpain N; Gibaja V; Paille F; Gillet P
Fundam Clin Pharmacol; 2017 Oct; 31(5):574-579. PubMed ID: 28322465
[TBL] [Abstract][Full Text] [Related]
2. Severe opioid withdrawal syndrome after a single dose of nalmefene.
Donnerstag N; Schneider T; Lüthi A; Taegtmeyer A; Raetz Bravo A; Mehlig A
Eur J Clin Pharmacol; 2015 Aug; 71(8):1025-6. PubMed ID: 26050241
[No Abstract] [Full Text] [Related]
3. Nalmefene Mistakenly Prescribed to Reduce Alcohol Consumption in Patients Under Buprenorphine Substitution Therapy Resulting in Acute Opioid Withdrawal: Management in an Emergency Setting.
Pélissier F; Rougé Bugat ME; Nubukpo P; Franchitto N
J Clin Psychopharmacol; 2016 Feb; 36(1):100-3. PubMed ID: 26658085
[No Abstract] [Full Text] [Related]
4. [Nalmefene and Opioid Withdrawal Syndrome: Analysis of the Global Pharmacovigilance Database for Adverse Drug Reactions].
Dahmke H; Kupferschmidt H; Kullak-Ublick GA; Weiler S
Praxis (Bern 1994); 2015 Oct; 104(21):1129-34. PubMed ID: 26463904
[TBL] [Abstract][Full Text] [Related]
5. Management of precipitated opiate withdrawal syndrome induced by nalmefene mistakenly prescribed in opiate-dependent patients: a review for clinicians.
Franchitto N; Jullian B; Salles J; Pelissier F; Rolland B
Expert Opin Drug Metab Toxicol; 2017 Jun; 13(6):669-677. PubMed ID: 28343423
[TBL] [Abstract][Full Text] [Related]
6. Opioid Receptor Antagonists in the Treatment of Alcoholism.
Serecigni JG
Adicciones; 2015 Sep; 27(3):214-30. PubMed ID: 26437315
[TBL] [Abstract][Full Text] [Related]
7. Comparing Nalmefene and Naltrexone in Alcohol Dependence: Are there any Differences? Results from an Indirect Meta-Analysis.
Soyka M; Friede M; Schnitker J
Pharmacopsychiatry; 2016 Mar; 49(2):66-75. PubMed ID: 26845589
[TBL] [Abstract][Full Text] [Related]
8. A novel non-opioid protocol for medically supervised opioid withdrawal and transition to antagonist treatment.
Rudolf G; Walsh J; Plawman A; Gianutsos P; Alto W; Mancl L; Rudolf V
Am J Drug Alcohol Abuse; 2018; 44(3):302-309. PubMed ID: 28795846
[TBL] [Abstract][Full Text] [Related]
9. Nalmefene for the treatment of alcohol use disorders: recent data and clinical potential.
Soyka M
Expert Opin Pharmacother; 2016; 17(4):619-26. PubMed ID: 26810044
[TBL] [Abstract][Full Text] [Related]
10. Pharmacotherapy for Substance Use Disorders.
Klein JW
Med Clin North Am; 2016 Jul; 100(4):891-910. PubMed ID: 27235620
[TBL] [Abstract][Full Text] [Related]
11. Nalmefene. Alcohol dependence: no advance.
Prescrire Int; 2014 Jun; 23(150):150-2. PubMed ID: 25121147
[TBL] [Abstract][Full Text] [Related]
12. [Illogical association nalmefene and opioids: Analysis in the French pharmacovigilance database].
Favrelière S; Lafay-Chebassier C; Fauconneau B; Quillet A; Yéléhé-Okouma M; Montastruc F; Pérault-Pochat MC
Therapie; 2019 Jun; 74(3):369-374. PubMed ID: 30197228
[TBL] [Abstract][Full Text] [Related]
13. Nalmefene for the treatment of alcohol dependence: a current update.
Soyka M
Int J Neuropsychopharmacol; 2014 Apr; 17(4):675-84. PubMed ID: 24246244
[TBL] [Abstract][Full Text] [Related]
14. Nalmefene for elective reversal of procedural sedation in children.
Chumpa A; Kaplan RL; Burns MM; Shannon MW
Am J Emerg Med; 2001 Nov; 19(7):545-8. PubMed ID: 11698998
[TBL] [Abstract][Full Text] [Related]
15. Naltrexone- or Nalmefene-Related Buprenorphine Withdrawal: Treat It With… More Buprenorphine.
Lescut C; Gaboriau L; Carton L; Rolland B
J Clin Psychopharmacol; 2017 Oct; 37(5):631-633. PubMed ID: 28806388
[No Abstract] [Full Text] [Related]
16. Rapid transition from methadone to buprenorphine using naltrexone-induced withdrawal: A case report.
Ward HB; Barnett BS; Suzuki J
Subst Abus; 2019; 40(2):140-145. PubMed ID: 30888254
[No Abstract] [Full Text] [Related]
17. Assessment of nalmefene glucuronide as a selective gut opioid antagonist.
Cheskin LJ; Chami TN; Johnson RE; Jaffe JH
Drug Alcohol Depend; 1995 Aug; 39(2):151-4. PubMed ID: 8529534
[TBL] [Abstract][Full Text] [Related]
18. A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence.
Gual A; He Y; Torup L; van den Brink W; Mann K;
Eur Neuropsychopharmacol; 2013 Nov; 23(11):1432-42. PubMed ID: 23562264
[TBL] [Abstract][Full Text] [Related]
19. Nalmefene for the management of alcohol dependence: review on its pharmacology, mechanism of action and meta-analysis on its clinical efficacy.
Mann K; Torup L; Sørensen P; Gual A; Swift R; Walker B; van den Brink W
Eur Neuropsychopharmacol; 2016 Dec; 26(12):1941-1949. PubMed ID: 27842940
[TBL] [Abstract][Full Text] [Related]
20. A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence.
Mason BJ; Salvato FR; Williams LD; Ritvo EC; Cutler RB
Arch Gen Psychiatry; 1999 Aug; 56(8):719-24. PubMed ID: 10435606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]